At Solvaro, the Synthesis CGU produces a solvent, traded on an active market, which it sells entirely to the group's Paints CGU at an internal price of 130 per tonne. Management estimates that future arm's length prices for the solvent will be around 100 per tonne. The Paints CGU shows indications of impairment and both values in use must be estimated. Which approach complies with IAS 36?
Single choiceExpertPublished